<DOC>
	<DOC>NCT00191919</DOC>
	<brief_summary>To determine the efficacy of Duloxetine vs. placebo on pain as determined by change in the Brief Pain Inventory (BPI) from baseline over 8 weeks of treatment</brief_summary>
	<brief_title>A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Major Depressive Disorder according to DSMIV criteria with at least one previous depressive episode in the patient's medical history Painful physical symptoms as measured by the Brief Pain InventoryShort Form Any anxiety disorder as a primary diagnosis within the past 6 months (including panic disorder, OCD, PTSD, generalized anxiety disorder and social phobia) Any diagnosis of bipolar disorder, schizophrenia, or other psychotic disorders</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>